Akif Altinbas

Akif Altinbas practices at Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut.

Akif Altinbas' NPI, 1346826328, was assigned on March 22, 2021. Akif Altinbas holds Connecticut license 75656.

Akif Altinbas' primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD, at 263 Farmington Ave, Farmington, CT 06030.

Akif Altinbas' primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut. Akif Altinbas is also affiliated with UConn John Dempsey Hospital. The medical group on file is UConn Medical Group. Dmand AI also links Akif Altinbas to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Akif Altinbas practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Akif Altinbas' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Akif Altinbas is licensed in Connecticut.

CMS data shows 347 Medicare services from Akif Altinbas across 10 procedure codes in 2024, for 142 Medicare patients. Medicare paid $24,770 for them. Every service was in an office.

CMS counts 142 Medicare patients who saw Akif Altinbas in 2024. The largest group is 65 to 74, with 64 patients. 67% of them have high blood pressure, and 65% have high cholesterol. 18% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Akif Altinbas' median patient age at 66, with 51% women.

In 2024, Akif Altinbas wrote 1,310 Medicare Part D claims for 264 patients. 86% of them were for generic drugs. CMS names the drug for 822 of them, across 31 drugs with 11 or more claims each, at $21,212 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Akif Altinbas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 41 papers to Akif Altinbas, published from 2010 to 2023. 2014 was the busiest year, with 7. The most frequent topics are Turkey, Liver Cirrhosis and Antiviral Agents. Akif Altinbas has published most often in Acta Gastroenterol Belg. Akif Altinbas' most frequent co-authors are Kara Wei Wei Chew, MD, Raymond T. Chung, MD and Steven Grant Deeks, MD.

CMS Open Payments shows 3 general payments to Akif Altinbas from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $114.